CoChat

Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

Open access
Munkholm, Klaus, Paludan-Müller, Asger Sand, Boesen, Kim · 2019 · BMJ Open

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Objectives: To investigate whether the conclusion of a recent systematic review and network meta-analysis (Cipriani et al) that antidepressants are more efficacious than placebo for adult depression was supported by the evidence. Design: Reanalysis of a systematic review, with meta-analyses. Data sources: 522 trials (116 477 participants) as reported in the systematic review by Cipriani et al and clinical study reports for 19 of these trials. Analysis: We used the Cochrane Handbook’s risk of bias tool and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to evaluate the risk of bias and the certainty of evidence, respectively. The impact of several study characteristics and publication status was estimated using pairwise subgroup meta-analyses. Results: Several methodological limitations in the evidence base of antidepressants were either unrecognised or underestimated in the systematic review by Cipriani et al. The effect size for antidepressants versus placebo on investigator-rated depression symptom scales was higher in trials with a ‘placebo run-in’ study design compared with trials without a placebo run-in design (p=0.05). The effect size of antidepressants was higher in published trials compared with unpublished trials (p<0.0001). The outcome data reported by Cipriani et al differed from the clinical study reports in 12 (63%) of 19 trials. The certainty of the evidence for the placebo-controlled comparisons should be very low according to GRADE due to a high risk of bias, indirectness of the evidence and publication bias. The mean difference between antidepressants and placebo on the 17-item Hamilton depression rating scale (range 0–52 points) was 1.97 points (95% CI 1.74 to 2.21). Conclusions: The evidence does not support definitive conclusions regarding the benefits of antidepressants for depression in adults. It is unclear whether antidepressants are more efficacious than placebo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2018-024886

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Previous meta-analyses reporting effect sizes for antidepressants versus placebo in adults. Data are reported as standardised mean differences with 95% CIs. NICE 20046: SSRIs. Kirsch 20088: ‘new generation’ antidepressants. Turner 20089: all antidepressants. Arroll 200941: antidepressants for depression in primary care. Data represent a pooled estimate of tricyclic antidepressants and SSRIs versus placebo, fixed-effects model. Fournier 201042: all antidepressants. Data represent pooled estimate from three groups of severity (mild to moderate, severe, very severe), fixed-effects model. Gibbons 201243: fluoxetine and venlafaxine. Jakobsen 20177: SSRIs. The effect size of mean change scores. Cipriani 20185: all antidepressants. SSRIs, selective serotonin reuptake inhibitors.
Figure 1 Previous meta-analyses reporting effect sizes for antidepressants versus placebo in adults. Data are reported as standardised mean differences with 95% CIs. NICE 20046: SSRIs. Kirsch 20088: ‘new generation’ antidepressants. Turner 20089: all antidepressants. Arroll 200941: antidepressants for depression in primary care. Data represent a pooled estimate of tricyclic antidepressants and SSRIs versus placebo, fixed-effects model. Fournier 201042: all antidepressants. Data represent pooled estimate from three groups of severity (mild to moderate, severe, very severe), fixed-effects model. Gibbons 201243: fluoxetine and venlafaxine. Jakobsen 20177: SSRIs. The effect size of mean change scores. Cipriani 20185: all antidepressants. SSRIs, selective serotonin reuptake inhibitors.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. Sharma T . Effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin - norepinephrine reuptake inhibitors (SNRIs) on suicidality, violence, and quality of life (PhD Thesis): University of Copenhagen, 2018.

Cited by

See all 166

Metadata

Authors
Munkholm, K., Paludan-Müller, A. S., & Boesen, K.
Affiliations
Rigshospitalet (DK)
Corresponding author
Munkholm, Klaus
Venue
BMJ Open
Publisher
BMJ
Published
2019-06
Volume
9
Issue
6
Pages
e024886
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2954134279
Cited by
151
References
43
Citations by year
2026: 13 · 2025: 15 · 2024: 17 · 2023: 31 · 2022: 20 · 2021: 29 · 2020: 15 · 2019: 11
FWCI
3.80
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • HighWire Press Open Archive (submittedVersion)
Funders
Nordic Cochrane Centre
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
Keywords
antidepressants, depression, placebo response, risk of bias, publication bias, clinical study reports, quality of evidence, Hamilton Depression Rating Scale, antidepressant efficacy
MeSH terms
Network Meta-Analysis, Network Meta-Analysis as Topic, Systematic Reviews as Topic, Adult, Antidepressive Agents, Depression, Humans, Meta-Analysis as Topic, Bias, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2018-024886
The paper
Munkholm, K., Paludan-Müller, A. S., & Boesen, K. (2019). Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2018-024886

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.